300485SZSE

Independent Director's 2025 Annual Work Report (Song Yanheng)

✨ AI Summary

This report outlines the performance of Song Yanheng as an independent director of Beijing Saisheng Pharmaceutical Co., Ltd. during 2025. Key activities included attending all board and shareholder meetings, chairing the audit committee, and ensuring compliance with legal requirements. The report emphasizes the protection of shareholder rights, particularly for minority shareholders, and the commitment to objective and independent decision-making.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Independent Director's 2025 Annual Work Report

As an independent director of Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), I, Song Yanheng, have strictly adhered to the provisions and requirements of the Company Law, Securities Law, Management Measures for Independent Directors of Listed Companies, and other relevant laws, regulations, normative documents, as well as the Articles of Association and the Independent Director Work System. With a responsible attitude towards all shareholders, I have diligently and faithfully fulfilled my duties as an independent director, providing objective, prudent, and fair independent opinions on significant matters of the Company, actively safeguarding the interests of the Company and the legal rights of shareholders, especially minority shareholders, and fully exerting the role of independent directors and members of the board's specialized committees. The following is my performance report for the 2025 term:

I. Basic Information of the Independent Director

(1) Work Experience, Professional Background, and Concurrent Positions

Song Yanheng, female, born in March 1973, Chinese nationality, without permanent residency abroad, holds a Ph.D. in Management from Tsinghua University, is a professor and doctoral supervisor, a non-practicing member of the Chinese Institute of Certified Public Accountants, a member of the Chinese Accounting Association, a council member of the ninth council of the Chinese Accounting Association, a member of the Corporate Accounting Standards Committee of the Chinese Accounting Association, and a national accounting leading talent (first academic category by the Ministry of Finance). Currently, I serve as the head of the Accounting and Financial Management Department at the International Business School of Beijing Foreign Studies University, focusing on research in financial, accounting, and auditing issues in China's capital market. I have published over 30 academic papers in core journals such as Management World, Accounting Research, and Audit Research, and have led two general projects and one youth project funded by the National Natural Science Foundation, participating in multiple national and provincial-level research projects. I have served as an independent director of the Company since January 26, 2024.

(2) Independence Statement

During my tenure as an independent director, I have not held any position in the Company other than that of independent director, nor have I held any position in the Company's major shareholders. There are no relationships with the Company or major shareholders that would hinder my ability to make independent and objective judgments, and there are no circumstances affecting the independence of independent directors. I comply with the relevant requirements regarding the independence of independent directors as stipulated in the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange, and the Articles of Association and Independent Director Work System of the Company.

II. Overview of Independent Director's Annual Performance

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.